These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31119568)

  • 1. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.
    Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S
    Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis.
    Mohankumar K; Li X; Sung N; Cho YJ; Han SJ; Safe S
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32099996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).
    Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S
    Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bis-Indole-Derived NR4A1 Ligands and Metformin Exhibit NR4A1-Dependent Glucose Metabolism and Uptake in C2C12 Cells.
    Mohankumar K; Lee J; Wu CS; Sun Y; Safe S
    Endocrinology; 2018 May; 159(5):1950-1963. PubMed ID: 29635345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy.
    Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
    Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.
    Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
    Mol Cell Biol; 2016 May; 36(9):1383-94. PubMed ID: 26929200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.
    Lee SO; Li X; Hedrick E; Jin UH; Tjalkens RB; Backos DS; Li L; Zhang Y; Wu Q; Safe S
    Mol Endocrinol; 2014 Oct; 28(10):1729-39. PubMed ID: 25099012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.
    Hedrick E; Lee SO; Safe S
    Mol Carcinog; 2017 Sep; 56(9):2066-2075. PubMed ID: 28418095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting NR4A1 (TR3) in cancer cells and tumors.
    Lee SO; Li X; Khan S; Safe S
    Expert Opin Ther Targets; 2011 Feb; 15(2):195-206. PubMed ID: 21204731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.
    Mohankumar K; Li X; Sridharan S; Karki K; Safe S
    Gynecol Oncol; 2019 Jul; 154(1):218-227. PubMed ID: 31053403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma.
    Hedrick E; Lee SO; Kim G; Abdelrahim M; Jin UH; Safe S; Abudayyeh A
    PLoS One; 2015; 10(6):e0128308. PubMed ID: 26035713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells.
    Lee SO; Jin UH; Kang JH; Kim SB; Guthrie AS; Sreevalsan S; Lee JS; Safe S
    Mol Cancer Res; 2014 Apr; 12(4):527-538. PubMed ID: 24515801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands.
    Upadhyay S; Hailemariam AE; Mariyam F; Hafiz Z; Martin G; Kothari J; Farkas E; Sivaram G; Bell L; Tjalkens R; Safe S
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.
    Lee SO; Abdelrahim M; Yoon K; Chintharlapalli S; Papineni S; Kim K; Wang H; Safe S
    Cancer Res; 2010 Sep; 70(17):6824-36. PubMed ID: 20660371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity.
    Karki K; Wright GA; Mohankumar K; Jin UH; Zhang XH; Safe S
    Cancer Res; 2020 Mar; 80(5):1011-1023. PubMed ID: 31911554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model.
    Andey T; Patel A; Jackson T; Safe S; Singh M
    Eur J Pharm Sci; 2013 Oct; 50(2):227-41. PubMed ID: 23892137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor Growth.
    Karki K; Mohankumar K; Schoeller A; Martin G; Shrestha R; Safe S
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells.
    Shrestha R; Mohankumar K; Jin UH; Martin G; Safe S
    Mol Cancer Ther; 2021 Mar; 20(3):612-622. PubMed ID: 33277444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells.
    Mohankumar K; Shrestha R; Safe S
    Mol Carcinog; 2022 Jan; 61(1):73-84. PubMed ID: 34699643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.
    Karki K; Li X; Jin UH; Mohankumar K; Zarei M; Michelhaugh SK; Mittal S; Tjalkens R; Safe S
    J Neurooncol; 2020 Jan; 146(1):25-39. PubMed ID: 31754919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.